Cargando…
Schizophrenia population health management: perspectives of and lessons learned from population health decision makers
BACKGROUND: Despite therapeutic advances for patients with schizophrenia, improving patient outcomes and reducing the cost of care continue to challenge formulary decision makers. OBJECTIVES: To (1) understand the perspectives of formulary decision makers on challenges to optimal schizophrenia popul...
Autores principales: | Roach, Meaghan, Lin, Dee, Graf, Marlon, Pednekar, Priti, Chou, Jacquelyn W, Benson, Carmela, Doshi, Jalpa A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408406/ https://www.ncbi.nlm.nih.gov/pubmed/34597157 http://dx.doi.org/10.18553/jmcp.2021.27.10-a.s1 |
Ejemplares similares
-
Dosing Schedules for Pneumococcal Conjugate Vaccine: Considerations for Policy Makers
por: Whitney, Cynthia G., et al.
Publicado: (2014) -
Racial and Ethnic Disparities in Long-Acting Injectable Antipsychotic Use in a National Sample of Medicare Beneficiaries With Schizophrenia
por: Li, Pengxiang, et al.
Publicado: (2023) -
Counting hard-to-count populations: the network scale-up method for public health
por: Bernard, H Russell, et al.
Publicado: (2010) -
Proceedings of the AMCP Integrated Care Summit: Population Health and Quality Improvement in Anaphylaxis
Publicado: (2014) -
Understanding the evolution of coverage policies for prophylaxis treatments of hemophilia A without inhibitors: a payer Delphi panel
por: Graf, Marlon, et al.
Publicado: (2021)